Avacta and Pall broaden drug discovery analysis partnership
This article was originally published in Clinica
Executive Summary
UK pharmaceutical and diagnostic services firm Avacta is teaming up with US filtration, separation and purification specialist Pall to provide analytical services to pharma companies, particularly in North America. They believe they can reduce the costs of drug discovery by screening molecules early in the development process to determine their functional properties, as well as optimising manufacturing and purification conditions.